Cargando…

A pilot study of risk-stratified cervical cancer screening

Background: Cervical screening programs target entire populations, although it is well established that cervical cancer risks can vary >100-fold based, in particular, on the woman’s screening history. Since cervical screening switched to Human Papillomavirus (HPV) testing as the primary screening...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jiangrong, Elfström, K. Miriam, Borgfeldt, Christer, Dillner, Joakim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	F1000 Research Limited 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445943/ https://www.ncbi.nlm.nih.gov/pubmed/37645164 http://dx.doi.org/10.12688/openreseurope.13398.2

Ejemplares similares

Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study
por: Wang, Jiangrong, et al.
Publicado: (2016)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden
por: Wang, Jiangrong, et al.
Publicado: (2017)

Cervical cancer case–control audit: Results from routine evaluation of a nationwide cervical screening program
por: Wang, Jiangrong, et al.
Publicado: (2019)

Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study
por: Andrae, Bengt, et al.
Publicado: (2019)

Cervical cancer screening in Sweden 2014-2016
por: Hortlund, Maria, et al.
Publicado: (2018)

Impact of HPV vaccination on cervical screening performance: a population-based cohort study
por: Lei, Jiayao, et al.
Publicado: (2020)

Atypical glandular cells and development of cervical cancer: Population‐based cohort study
por: Norman, Ingrid, et al.
Publicado: (2022)

Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial
por: Elfström, K. Miriam, et al.
Publicado: (2021)

The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer
por: Barrett, James E., et al.
Publicado: (2022)

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study
por: Lei, Jiayao, et al.
Publicado: (2018)

Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
por: Persson, Maria, et al.
Publicado: (2015)

Co‐testing in cervical screening among 40‐ to 42‐year‐old women is unreasonable
por: Borgfeldt, Christer, et al.
Publicado: (2022)

Promotion of Cervical Screening among Long-term Non-attendees by Human Papillomavirus Self-sampling
por: Ernstson, Avalon, et al.
Publicado: (2021)

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
por: Lagheden, Camilla, et al.
Publicado: (2018)

Cervical cancer prevention among long-term screening non-attendees by vaginal self-collected samples for hr-HPV mRNA detection
por: Ernstson, Avalon, et al.
Publicado: (2020)

Risk of high-grade lesions after atypical glandular cells in cervical screening: a population-based cohort study
por: Norman, Ingrid, et al.
Publicado: (2017)

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
por: Elfström, K Miriam, et al.
Publicado: (2014)

Predicting past and future SARS-CoV-2-related sick leave using discrete time Markov modelling
por: Lei, Jiayao, et al.
Publicado: (2022)

Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme
por: Nygård, Mari, et al.
Publicado: (2014)

Estimating total excess mortality during a COVID-19 outbreak in Stockholm, Sweden
por: Pimenoff, Ville N, et al.
Publicado: (2020)

Validation of the cobas 6800 human papillomavirus test in primary cervical screening
por: Sundström, Karin, et al.
Publicado: (2021)

Risk for SARS-CoV-2 infection in healthcare workers outside hospitals: A real-life immuno-virological study during the first wave of the COVID-19 epidemic
por: Fröberg, Maria, et al.
Publicado: (2021)

Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56–60
por: Lamin, Helena, et al.
Publicado: (2017)

Potential SARS-CoV-2 infectiousness among asymptomatic healthcare workers
por: Pimenoff, Ville N., et al.
Publicado: (2021)

HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis
por: Mekuria, Selamawit F., et al.
Publicado: (2023)

Exposure Definition in Case–Control Studies of Cervical Cancer Screening: A Systematic Literature Review
por: Castanon, Alejandra, et al.
Publicado: (2021)

Screening and cervical cancer cure: population based cohort study
por: Andrae, Bengt, et al.
Publicado: (2012)

Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?
por: Sundström, Karin, et al.
Publicado: (2020)

Time Trends for Incidence and Net Survival of Cervical Cancer in Sweden 1960–2014—A Nationwide Population-Based Study
por: Sundqvist, Avalon, et al.
Publicado: (2022)

European guidelines for quality assurance in cervical cancer screening. Summary of the supplements on HPV screening and vaccination
por: von Karsa, Lawrence, et al.
Publicado: (2015)

Barriers to and Facilitators of Compliance with Clinic-Based Cervical Cancer Screening: Population-Based Cohort Study of Women Aged 23-60 Years
por: Östensson, Ellinor, et al.
Publicado: (2015)

Cervical neoplasia in relation to socioeconomic and demographic factors – a nationwide cohort study (2002–2018)
por: Jansåker, Filip, et al.
Publicado: (2022)

Risks of non-ovarian cancers in women with borderline ovarian tumor: a national cohort study in Sweden
por: Dobilas, Arturas, et al.
Publicado: (2023)

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders
por: Lam, J U H, et al.
Publicado: (2018)

DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test
por: Herzog, Chiara, et al.
Publicado: (2022)

Importance of International Networking and Comparative Research in Screening to Meet the Global Challenge of Cancer Control
por: Broeders, Mireille, et al.
Publicado: (2020)

Correction: Barriers to and Facilitators of Compliance with Clinic-Based Cervical Cancer Screening: Population-Based Cohort Study of Women Aged 23-60 Years
por: Östensson, Ellinor, et al.
Publicado: (2015)

Differences in risk for SARS-CoV-2 infection among healthcare workers
por: Elfström, K. Miriam, et al.
Publicado: (2021)

Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
por: de Kok, Inge M C M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ejqb0crukvgkcqt1iu5ev2j167